Jefferies downgrades Australia's Monash IVF, casts doubt on medium-term demand

Monash IVF

12/05/2022 21:55

** Jefferies downgrades Australian assisted reproductive
services provider Monash IVF  MVF.AX  amid doubts about how much
demand co will see in the medium-term
    ** MVF on Thursday forecast slightly lower FY adj NPAT due
to COVID-19 curbs in Australia, which it said had created
pent-up demand to be serviced in the future  urn:newsml:reuters.com:*:nASX8Cn5Tq
    ** "We worry about potentially lower levels of discretionary
spend in Australia leading to lower volumes of IVF in the
medium-term," Jefferies analysts say in a note
    ** Brokerage cuts rating to "hold" from "buy", lowers PT to
A$1.25 from A$1.32
    ** Four of 5 brokerages rate the stock "buy", 1 "hold";
median PT A$1.25 - Refinitiv data
    ** Up to Thursday's close, stock up 4.3% this year

 (Reporting by Shashwat Awasthi)
 ((Shashwat.Awasthi@tr.com
mailto:Shashwat.Awasthi@thomsonreuters.com))